CXCL1 and Insulin resistance: These data are consistent with those from two other studies which demonstrated that application of CXCL1 to cultured adipocytes enhanced inflammation, inducing release of leptin, monocyte chemotactic protein-1 (MCP-1), IL-6, and TNF, as well as SOCS3, a factor known to mediate insulin resistance (97, 108).